FDA Clearance Tracker · P200039-S019
Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Aero Fly Coronary Intravascular Lithotripsy (IVL) Cat
Last checked: Nov 20, 2026Latest source record: Feb 20, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 20, 2026
Approved
Time to decision
93 days
Received Nov 19, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P200039-S019
- Device name
- Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Aero Fly Coronary Intravascular Lithotripsy (IVL) Cat
- Applicant
- Shockwave Medical, Inc.
- Applicant location
- Santa Clara, CA
- Received
- Nov 19, 2025
- Decided
- Feb 20, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P200039
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
approval for the C2 Aero Fly Coronary Intravascular Lithotripsy (IVL) Catheter with higher pulse rate and shorter pause time than the C2 Aero Coronary Intravascular Lithotripsy (IVL) Catheter approved under P200039/S015
Source documents
Other decisions for Shockwave Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter510(k)
K262201 · Decided Jul 27, 2026 · 28 days after receipt
Device type: Percutaneous Catheter, Ultrasound (PPN) · Cardiology
K243757 · Decided May 2, 2025 · 147 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
K242213 · Decided Sep 27, 2024 · 60 days after receipt
Device type: Percutaneous Catheter, Ultrasound (PPN) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.